连续血糖监测仪准确性测量的临床意义
Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors.
作者信息
Bailey Timothy S
机构信息
AMCR Institute , Escondido, California.
出版信息
Diabetes Technol Ther. 2017 May;19(S2):S51-S54. doi: 10.1089/dia.2017.0050.
Abstract
The accuracy of a continuous glucose monitor (CGM) now supports its use by persons with diabetes and clinicians caring for them. This article reviews measures of CGM accuracy, factors contributing to accuracy, comparative accuracy assessment, clinical implications of CGM sensor accuracy, and recent clinical trials that have demonstrated the utility of CGMs.
摘要
连续血糖监测仪（CGM）的准确性如今支持糖尿病患者及其护理临床医生使用该设备。本文回顾了CGM准确性的衡量指标、影响准确性的因素、准确性的比较评估、CGM传感器准确性的临床意义以及近期证明CGM效用的临床试验。
相似文献
1
Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors.
Diabetes Technol Ther. 2017 May;19(S2):S51-S54. doi: 10.1089/dia.2017.0050.
2
Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies.
Diabetes Technol Ther. 2016 Feb;18 Suppl 2(Suppl 2):S223-33. doi: 10.1089/dia.2015.0380.
3
Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
Diabetes Technol Ther. 2015 Mar;17(3):177-86. doi: 10.1089/dia.2014.0272. Epub 2014 Dec 1.
4
Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices.
J Diabetes Sci Technol. 2019 May;13(3):575-583. doi: 10.1177/1932296818812062. Epub 2018 Nov 19.
5
Unlocking the potential of continuous glucose monitoring: a new guideline supports the development of continuous glucose monitoring devices.
J Diabetes Sci Technol. 2009 Mar 1;3(2):363-5. doi: 10.1177/193229680900300218.
6
Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems.
J Diabetes Sci Technol. 2024 Jul;18(4):857-865. doi: 10.1177/19322968221134639. Epub 2022 Nov 3.
7
Accuracy Evaluation of a CE-Marked Glucometer System for Self-Monitoring of Blood Glucose With Three Reagent Lots Following ISO 15197:2013.
J Diabetes Sci Technol. 2017 May;11(3):635-636. doi: 10.1177/1932296816670401. Epub 2016 Oct 4.
8
Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice.
Diabetes Technol Ther. 2019 Jun;21(S2):S217-S225. doi: 10.1089/dia.2019.0034.
9
[CGM-Continuous Glucose Monitoring--Statement of the Austrian Diabetes Association].
Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S184-7. doi: 10.1007/s00508-016-0958-0.
10
Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes.
Methods Enzymol. 2009;454:69-86. doi: 10.1016/S0076-6879(08)03803-2.
引用本文的文献
1
Real-time converter of intermittent-scanned glucose sensors to continuous glucose monitors with potential future applications for insulin delivery.
HardwareX. 2025 Aug 19;23:e00684. doi: 10.1016/j.ohx.2025.e00684. eCollection 2025 Sep.
2
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.
J Diabetes Sci Technol. 2023 Nov;17(6):1506-1526. doi: 10.1177/19322968231190941. Epub 2023 Aug 20.
3
Evaluating the Clinical Accuracy of a Non-invasive Single-Fasting-Calibration Glucometer in Patients with Diabetes: A Multicentre Study.
Diabetes Ther. 2023 Jun;14(6):989-1004. doi: 10.1007/s13300-023-01402-8. Epub 2023 Apr 27.
4
Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems.
J Diabetes Sci Technol. 2024 Jul;18(4):857-865. doi: 10.1177/19322968221134639. Epub 2022 Nov 3.
5
Accuracy of an Off-Label Transmitter and Data Manager Paired With an Intermittent Scanned Continuous Glucose Monitor in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2024 May;18(3):701-708. doi: 10.1177/19322968221133405. Epub 2022 Oct 25.
6
Catalytic Biosensors Operating under Quasi-Equilibrium Conditions for Mitigating the Changes in Substrate Diffusion.
Angew Chem Int Ed Engl. 2022 Dec 23;61(52):e202211559. doi: 10.1002/anie.202211559. Epub 2022 Nov 23.
7
Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices.
Theranostics. 2022 Jan 1;12(2):493-511. doi: 10.7150/thno.64035. eCollection 2022.
8
Non-invasive and minimally invasive glucose monitoring devices: a systematic review and meta-analysis on diagnostic accuracy of hypoglycaemia detection.
Syst Rev. 2021 May 10;10(1):145. doi: 10.1186/s13643-021-01644-2.
9
Fifteen-minute consultation: Practical use of continuous glucose monitoring.
Arch Dis Child Educ Pract Ed. 2022 Jun;107(3):188-193. doi: 10.1136/archdischild-2020-321190. Epub 2021 May 7.
10
Smart wearable devices in cardiovascular care: where we are and how to move forward.
Nat Rev Cardiol. 2021 Aug;18(8):581-599. doi: 10.1038/s41569-021-00522-7. Epub 2021 Mar 4.
本文引用的文献
1
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.
2
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976.
3
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
JAMA. 2017 Jan 24;317(4):371-378. doi: 10.1001/jama.2016.19975.
4
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
Diabetes Ther. 2017 Feb;8(1):55-73. doi: 10.1007/s13300-016-0223-6. Epub 2016 Dec 20.
5
Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges.
Sensors (Basel). 2016 Dec 9;16(12):2093. doi: 10.3390/s16122093.
6
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Lancet. 2016 Nov 5;388(10057):2254-2263. doi: 10.1016/S0140-6736(16)31535-5. Epub 2016 Sep 12.
7
From Two to One Per Day Calibration of Dexcom G4 Platinum by a Time-Varying Day-Specific Bayesian Prior.
Diabetes Technol Ther. 2016 Aug;18(8):472-9. doi: 10.1089/dia.2016.0088.
8
FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM.
Diabetes Technol Ther. 2016 Aug;18(8):512-6. doi: 10.1089/dia.2016.07252.mr. Epub 2016 Jul 29.
9
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Diabetes Technol Ther. 2016 Feb;18 Suppl 2(Suppl 2):S234-42. doi: 10.1089/dia.2015.0369.
10
Performance Comparison of CGM Systems: MARD Values Are Not Always a Reliable Indicator of CGM System Accuracy.
J Diabetes Sci Technol. 2015 Sep 1;9(5):1030-40. doi: 10.1177/1932296815586013. Print 2015 Sep.
Zotero 插件